Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Venlafaxine sustained-release capsule composition and preparation process thereof

A technology of sustained-release capsules and venlafaxine, which is applied in the field of medicine and can solve problems such as complex structure of coating devices, increased costs, and complex ingredients of antidepressants

Pending Publication Date: 2021-02-26
HAINAN WEI KANG PHARMA QIANSHAN
View PDF10 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The antidepressant drugs in the prior art have complex components and high requirements on the production equipment, which greatly increases the production cost, and when the drug is coated, the structure of the coating device is also complicated, and the tiny particles are coated easy reunion problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Venlafaxine sustained-release capsule composition and preparation process thereof
  • Venlafaxine sustained-release capsule composition and preparation process thereof
  • Venlafaxine sustained-release capsule composition and preparation process thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Composition of drug-containing pill core: Venlafaxine hydrochloride 34.8%, microcrystalline cellulose 58%, hydroxypropyl methylcellulose 0.53%, sustained-release coating components (5.5%) including ethyl cellulose and hydroxypropyl methylcellulose Cellulose, ethanol.

[0055] The preparation method is:

[0056] (1) Venlafaxine hydrochloride and microcrystalline cellulose are mixed;

[0057] (2) adding a mixed aqueous solution of hydroxypropylmethylcellulose to the resulting mixture;

[0058] (3) Extrude, spheronize, and dry to obtain a pill core;

[0059] (4) Coating the pill core with a coating solution to obtain sustained-release pellets;

[0060] (5) Put the sustained-release pellets into hollow capsules to obtain venlafaxine hydrochloride sustained-release capsules.

[0061] The sustained-release capsules have a specification of 150mg.

Embodiment 2

[0063] Composition of pill core: venlafaxine hydrochloride 34.9%, microcrystalline cellulose 58.5%, hydroxypropyl methylcellulose 0.52%, sustained-release coating components (5.3%) including ethyl cellulose, hydroxypropyl methylcellulose Cellulose, ethanol.

[0064] The preparation method is:

[0065] (1) Venlafaxine hydrochloride and microcrystalline cellulose are mixed;

[0066] (2) adding a mixed aqueous solution of hydroxypropylmethylcellulose to the resulting mixture;

[0067] (3) Extrude, spheronize, and dry to obtain a pill core;

[0068] (4) Coating the pill core with a coating solution to obtain sustained-release pellets;

[0069] (5) Put the sustained-release pellets into hollow capsules to obtain venlafaxine hydrochloride sustained-release capsules.

[0070] The sustained-release capsules have a specification of 150mg.

[0071] Such as Figure 1 to Figure 6 As shown, the coating device includes a feeding mechanism 1 and a coating mechanism 2, the feeding mecha...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a venlafaxine sustained-release capsule composition and a preparation process thereof. The composition comprises a hollow capsule and a sustained-release pellet in a hollow capsule shell, wherein the sustained-release pellet is composed of a drug-containing pellet core and a sustained-release coating, the drug-containing pellet core comprises venlafaxine hydrochloride, microcrystalline cellulose and hydroxypropyl methyl cellulose, and the sustained-release coating comprises ethyl cellulose and hydroxypropyl methyl cellulose. The invention further provides a preparationmethod of the capsule. The method is simple in process, mild in condition, simple in preparation, few in auxiliary material variety and dosage, low in equipment requirement and suitable for industrialproduction. The invention further discloses a coating device. Venturi tube design is adopted in a forming and separating device of the coating device, materials input from a solid-phase feeding holeare impacted, drug particles adhering after coating are separated, the coating on the surfaces of the particles can be cooled and cured through low-temperature nitrogen, and the situation that the drug particles adhere again subsequently, and consequently drug processing is affected is avoided.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a venlafaxine sustained-release capsule composition and a preparation process thereof. Background technique [0002] Depression is one of the serious mental illnesses with high prevalence, high relapse rate, high disease burden and high autologous mortality. It is a group of mood disorders or affective disorders caused by various reasons, with depression as the main symptom, and a group of clinical symptoms centered on depressed mood and self-situation. At present, traditional Chinese medicine mainly treats depression by invigorating the kidney, soothing the liver and relieving depression, and regulating the balance of yin and yang, but there is still a lack of basic research to clarify its mechanism of action, and there is still a lack of objective and standardized research on how to differentiate depression. Western medicine mostly adopts drug therapy, such as ant...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/62A61K47/38A61K31/137A61P25/24A61J3/00
CPCA61K9/5089A61K9/5047A61K9/5042A61K31/137A61P25/24A61J3/005
Inventor 马莉李珠珠史权杰
Owner HAINAN WEI KANG PHARMA QIANSHAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com